$NBIX 4/A SEC Filings

Filed On	Filing
16 Jan 2026	Form 4/A: Benevich Eric, Chief Commercial Officer Received 12,830 shares by exercise or conversion ($462K)
11 May 2023	Form 4/A: Benevich Eric, Chief Commercial Officer Holds 15,829 shares of Common Stock
11 May 2023	Form 4/A: Benevich Eric, Chief Commercial Officer Holds 16,960 shares of Common Stock
11 May 2023	Form 4/A: Lippoldt Darin, Chief Legal Officer Holds 30,182 shares of Common Stock
03 May 2023	Form 4/A: Cooke Julie, Chief Human Resources Officer Holds 9,554 shares of Common Stock
26 Apr 2023	Form 4/A: Roberts Eiry, Chief Medical Officer Holds 13,506 shares of Common Stock
29 Mar 2021	Form 4/A: Roberts Eiry, Chief Medical Officer Granted 49,049 Stock Option
29 Mar 2021	Form 4/A: Lloyd-Smith Malcolm, Chief Regulatory Officer Granted 35,035 Stock Option
29 Mar 2021	Form 4/A: Lippoldt Darin, Chief Legal Officer Granted 45,546 Stock Option
29 Mar 2021	Form 4/A: Grigoriadis Dimitri E., Chief Research Officer Granted 42,042 Stock Option
29 Mar 2021	Form 4/A: Gorman Kevin Charles, Director Granted 113,863 Stock Option
29 Mar 2021	Form 4/A: Gano Kyle, Chief Business Development Off Granted 49,049 Stock Option
29 Mar 2021	Form 4/A: Cooke Julie, Chief Human Resources Officer Granted 35,035 Stock Option
29 Mar 2021	Form 4/A: Bozigian Haig P., Chief Development Officer Granted 3,504 Stock Option
26 Mar 2021	Form 4/A: Benevich Eric, Chief Commercial Officer Granted 49,049 Stock Option
26 Mar 2021	Form 4/A: Abernethy Matt, Chief Financial Officer Granted 49,049 Stock Option
24 May 2016	Form 4/A: Pops Richard F, Director Granted 25,000 Stock Option
24 May 2016	Form 4/A: Rastetter William H, Director Granted 30,000 Stock Option
24 May 2016	Form 4/A: Mollica Joseph A, Director Granted 25,000 Stock Option
24 May 2016	Form 4/A: Mitchell W Thomas, Director Granted 25,000 Stock Option

Comments